Atlas Trials

Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects

Clinical trial NCT02404233 · UNKNOWN

Trial details

NCT number
NCT02404233
Sponsor
Therapeutic Concepts
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HIV Positive
Start date
2015-03-01
Primary completion
2016-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.